| Literature DB >> 34205667 |
Pedro Silva-Vaz1,2,3,4, Ivana Jarak5, Luís Rato6, Pedro F Oliveira7, Sara Morgado-Nunes4,8, Aida Paulino2,3,4, Miguel Castelo-Branco1,3,4, Maria Filomena Botelho9,10,11,12, José Guilherme Tralhão9,10,11,12,13, Marco G Alves14, Ana Margarida Abrantes9,10,11,12.
Abstract
Acute pancreatitis (AP) is an inflammatory process of the pancreas with variable involvement of the pancreatic and peripancreatic tissues and remote organ systems. The main goal of this study was to evaluate the inflammatory biomarkers, oxidative stress (OS), and plasma metabolome of patients with different degrees of biliary AP severity to improve its prognosis. Twenty-nine patients with biliary AP and 11 healthy controls were enrolled in this study. We analyzed several inflammatory biomarkers, multifactorial scores, reactive oxygen species (ROS), antioxidants defenses, and the plasma metabolome of biliary AP and healthy controls. Hepcidin (1.00), CRP (0.94), and SIRI (0.87) were the most accurate serological biomarkers of AP severity. OS played a pivotal role in the initial phase of AP, with significant changes in ROS and antioxidant defenses relating to AP severity. Phenylalanine (p < 0.05), threonine (p < 0.05), and lipids (p < 0.01) showed significant changes in AP severity. The role of hepcidin and SIRI were confirmed as new prognostic biomarkers of biliary AP. OS appears to have a role in the onset and progression of the AP process. Overall, this study identified several metabolites that may predict the onset and progression of biliary AP severity, constituting the first metabonomic study in the field of biliary AP.Entities:
Keywords: acute biliary pancreatitis; hepcidin; inflammation; metabonomics; oxidative stress; prognostic; severity; systemic inflammatory response index
Year: 2021 PMID: 34205667 DOI: 10.3390/antiox10060988
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921